MIGRABAN DIN 02238143
Status: Cancelled Post Market
Holder: JAMIESON LABORATORIES LTD
Molecule: PARTHENOLIDE (FEVERFEW)
Available to quote
Health Canada record
| Active ingredient(s) | PARTHENOLIDE (FEVERFEW) 250 MCG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | |
| Original market date | 13-Nov-1998 |
| Current status date | 01-Jul-2004 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamieson Laboratories Ltd. — licence 100166, currently licensed, last inspection rating C (2022-05-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PARTHENOLIDE (FEVERFEW)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02237321 | FEVERFEW 125MG | NATURAL FACTORS NUTRITIONAL PRODUCTS LTD. | Capsule | PARTHENOLIDE (FEVERFEW) 0.25 MG | Cancelled Post Market |
| 02235601 | MIGRAWAY | NUTRAVITE PHARMACEUTICALS INC. | Capsule | PARTHENOLIDE (FEVERFEW) 280 MCG | Cancelled Post Market |